WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 1.93.
| Share Price | ₹761.0 | Jan 08,2026 |
| Market Cap | ₹1,605.7 Cr | |
| Sales-TTM | ₹830.2 Cr | TTM-Consolidated Results |
| Price/Sales | 1.93x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,605.7 Cr] as on Jan 08,2026
(/) Sales [ ₹830.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.93x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '1.93 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.29x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 0.98x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2025 at 2.87x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WINDLAS BIOTECH | 830.2 | 1.93 | 1,605.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.69 | 422,631.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.46 | 175,111.0 |
| CIPLA LTD | 28,349.6 | 4.16 | 117,983.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.12 | 136,228.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.94 | 100,782.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.86 | 93,157.7 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.73 | 91,325.8 |
| LUPIN LTD | 24,750.7 | 4.04 | 100,062.0 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.16 | 70,091.1 |
| ABBOTT INDIA LTD | 6,714.4 | 8.97 | 60,208.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.93x |
| Max industry PS | 17.46x |
| Median industry PS | 4.16x |
| Average industry PS | 6.46x |
You may also like the below Video Courses